Home » Abbott in New Deal to Target Emerging Markets
Abbott in New Deal to Target Emerging Markets
Abbott Laboratories will license at least 24 products in emerging markets through a new unit created to boost sales outside of the U.S., the drug and medical device maker said Tuesday.
WTOP
WTOP
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May